Highest-materiality recent filing
IPG Photonics Q1 revenue up 17% to $265.5M; settles global patent litigation with Trumpf
Revenue $265.5M (+17% YoY); GAAP diluted EPS $0.04, adjusted EPS $0.29.
UPC rules IPG's AMB lasers infringe Trumpf patent; <1% of sales affected
UPC Mannheim Local Division found certain AMB laser designs infringe European Patent 2,951,625.
IPG Photonics Q4 2025 revenue up 17% YoY, adjusted EPS $0.46, authorizes $100M buyback
Q4 revenue $274.5M (+17% YoY); GAAP net income $13.3M ($0.31 EPS); adjusted EPS $0.46 (+53%).
IPG Q3 2025 revenue $251M (+8% YoY); GAAP EPS $0.18, adj. EPS $0.35; guides Q4 rev $230-260M
Q3 2025 revenue $250.8M (+8% YoY); GAAP net income $7.5M vs loss of $233.6M in prior year.
IPG Photonics Q2 revenue $250.7M above expectations; guides Q3 $225-255M
GAAP EPS $0.16 vs $0.45 a year ago; adjusted EPS $0.30 vs $0.52.
IPG Photonics Q1 rev $228M (-10% YoY); GAAP EPS $0.09; Q2 guidance reflects tariff delays
Revenue $227.8M (-10% YoY); net income $3.8M ($0.09 diluted EPS) vs $24.1M ($0.52) a year ago.
IPG Photonics Q4 revenue down 22% to $234M; EPS $0.18 (-80%); CAO change; weak Q1 guidance
Q4 revenue $234.3M (-22% YoY); EPS $0.18 (-80% from $0.89); net income $7.8M vs $41.4M.
IPG Photonics reports Q3 loss of $5.33/share, guides Q4 EPS $0.05-$0.35, acquires cleanLASER
Q3 revenue $233.1M (-23% YoY); GAAP diluted EPS loss $5.33; adjusted EPS $0.29.
IPG Photonics sells Russian subsidiary IRE-Polus for $51M; expects $195-210M in charges
Sale proceeds $51M before fees; charges $195-210M including $60-65M net asset write-down and $135-145M translation loss.
IPG Photonics Q2 revenue $258M (-24% YoY), EPS $0.45; guides Q3 rev $210-240M, EPS $0.00-0.30
Revenue $258M, down 24% YoY; EPS $0.45 vs $1.31, down 66%.
IPG Photonics Q1 revenue down 27% to $252M, appoints Mark Gitin as CEO
Q1 revenue $252M (-27% YoY); diluted EPS $0.52 (-59% YoY); gross margin 38.7% (-360 bps).
Dr. Mark Gitin, previously EVP at MKS Instruments, named CEO effective June 5, 2024, succeeding Dr. Eugene Scherbakov.
IPG Photonics Q4 revenue $299M (-10% YoY); EPS $0.89 vs loss $1.91
Revenue $298.9M, down 10% YoY; gross margin improved to 38.2% from 18.2%.
Mr. Michael C. Child, a member of the of the Board of Directors of IPG Photonics Corporation (the " Company "), informed the Company on March 6, 2025 that he will not stand for re-election at the 2025 annual meeting of stockholders.
On February 7, 2025, the Board of Directors (the " Board ") of the Company appointed the Company's Vice President, Finance, Mary E. Buttarazzi, to assume the role of the Company's Vice President, Corporate Controller and Chief Accounting Officer (including its Principal Accounting Officer) effective upon Mr. Burgomaster’s retirement on March 1, 2025.
On February 7, 2025, Thomas J. Burgomaster, Vice President, Corporate Controller and Chief Accounting Officer (including its Principal Accounting Officer) of the Company, informed the Company of his intention to retire from his position with the Company effective March 1, 2025.
Dr. Eugene Scherbakov and Dr. Alexander Ovtchinnikov, previously disclosed as named executive officers of the Company, will not participate in the Revised AIP as a result of no longer being executive officers of the Company.
Dr. Eugene Scherbakov and Dr. Alexander Ovtchinnikov, previously disclosed as named executive officers of the Company, will not participate in the Revised AIP as a result of no longer being executive officers of the Company.
On August 15, 2024, Alexander Ovtchinnikov, Ph.D., Senior Vice President, Chief Technology Officer of IPG Photonics Corporation (the “Company”), informed the Company of his intention to retire from employment with the Company effective September 15, 2024
the Board of Directors (the “Board”) of IPG Photonics Corporation (the “Company”) appointed Dr. Mark Gitin as Chief Executive Officer of the Company, effective June 5, 2024
The Board has also determined to increase the size of the Board to eleven directors and to appoint Dr. Gitin as a director to fill such vacancy, subject to Dr. Gitin commencing employment with the Company and effective as of the Start Date.
Dr. Eugene Scherbakov will transition from his role as the Company’s Chief Executive Officer, effective as of June 5, 2024
Max materiality 0.80 · Median 0.60 · Most common event earnings